Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1204 (LINC01204) is a long intergenic non-coding RNA (lincRNA) gene in the human genome [3][4]. LincRNAs are transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes and are a subclass of long non-coding RNAs [5][7]. They function mainly in the regulation of gene expression, often through mechanisms such as chromatin remodeling, transcriptional regulation, stabilization of RNA, and enhancer-like activities, and may show tissue-specific expression patterns[5][7][9]. While some lincRNAs have established roles in the regulation of neighboring genes or in disease processes (notably cancer)[5], the specific functions and disease associations of LINC01204 remain largely uncharacterized in the current literature[1][4]. There are no approved drugs targeting this RNA and it is not a standard therapeutic target like enzymes or receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1204 (LINC01204).